Around 80 percent of patients who developed health issues after consuming Kobayashi Pharmaceutical Co. red yeast rice dietary supplements went to the hospital in January or later, a study by the Japanese Society of Nephrology showed Monday.The online survey analyzed 47 cases reported by the society's member doctors between Wednesday and Sunday, following recent revelations of five deaths and over 100 hospitalizations among those who consumed the Osaka-based drugmaker's supplements containing "beni-koji" red yeast rice.Among the patients, 90 percent were aged between 40 and 69, with 66 perce…READ FULL ARTICLE